Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Obinutuzumab Chemical Structure
BCP25211 Obinutuzumab 949142-50-1
Obinutuzumab (called afutuzumab until 2009,originally GA101) is a humanized anti-CD20 monoclonal antibody as a cancer treatment.
Secukinumab Chemical Structure
BCP26257 Secukinumab 875356-43-7
Secukinumab is a human IgG1κ monoclonal antibody that binds to the protein interleukin (IL)-17A.
Daratumumab Chemical Structure
BCP23828 Daratumumab 945721-28-8
Daratumumab is an IgG1k monoclonal antibody directed against CD38.
Blinatumomab Chemical Structure
BCP28744 Blinatumomab 853426-35-4
Blinatumomab specifically targets the CD19 antigen present on B cells.
Nimotuzumab Chemical Structure
BCP25910 Nimotuzumab 828933-51-3;780758-10-3
Nimotuzumab is a humanized monoclonal antibody and binds with optimal affinity and high specificity to the extracellular region of EGFR (epidermal growth factor receptor).
Adecatumumab Chemical Structure
BCP29455 Adecatumumab 503605-66-1
Adecatumumab is a recombinant human IgG1 monoclonal antibody which is used to target tumor cells.
Ipilimumab Chemical Structure
BCP25419 Ipilimumab 477202-00-9
Ipilimumab is a monoclonal antibody that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system.
Aducanumab Chemical Structure
BCP24776 Aducanumab 1384260-65-4
Aducanumab targets aggregated forms of β-amyloid (Aβ) in the hopes of reducing its buildup.
Avelumab Chemical Structure
BCP25212 Avelumab 1537032-82-8
Avelumab is a fully human IgG1 anti-PD-L1 monoclonal antibody with potential antibody-dependent cell-mediated cytotoxicity.
Durvalumab Chemical Structure
BCP25841 Durvalumab 1428935-60-7
Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody that blocks the interaction of programmed cell death ligand 1 (PD-L1) with the PD-1 and CD80 (B7.1) molecules.
123下一页末页共 36 条记录 1 / 4 页